Formulari Ubat KKM (FUKKM)

# Generic Name MDC Category Indications Dosage
1531 Terazosin HCl 2 mg Tablet G04CA03110T1002XX A/KK i) Treatment of Benign Prostatic Hyperplasia. ii)Hypertension i)Initially 1 mg at night, increased in a stepwise fashion to 2 mg, 5 mg or 10 mg once daily. ii)Initial: 1mg once daily at bedtime, Maintenance: 1-5mg once (morning or evening) or twice daily. Max: 20-40mg/day
1532 Terazosin HCl 5 mg Tablet G04CA03110T1003XX A/KK i) Treatment of Benign Prostatic Hyperplasia. ii)Hypertension i) Initially 1 mg at night, increased in a stepwise fashion to 2 mg, 5 mg or 10 mg once daily. ii) Initial: 1mg once daily at bedtime, Maintenance: 1-5mg once (morning or evening) or twice daily. Max: 20-40mg/day
1533 Terbinafine 1% gel D01AE15110G3001XXX A/KK Skin infections caused by dermatophytes, mould and candida. Prescribing restriction: Second line treatment Apply topically twice daily for 1 week (interdigital); apply topically twice (plantar) daily for 2 weeks. Children must be aged above 2 years old.
1534 Terbinafine HCl 250 mg Tablet D01BA02110T1001XX A/KK Fungal infections especially onchomycosis caused by dermatophytes 250 mg once daily for 6 weeks for fingernails: 12 weeks for toenails
1535 Terbutaline Sulphate 0.5 mg/ml Injection R03CC03183P3001XX B Bronchial asthma, chronic bronchitis, emphysema and other lung diseases where broncoconstriction is a complicating factor SC, IM or slow IV : 250-500 mcg up to 4 times daily. CHILD 2 - 15 years 10mcg/kg to a maximum of 300 mcg. Continuous IV infusion, as a solution containing 3 - 5 mcg/ml, 1.5 - 5 mcg/minute for 8 - 10 hours; reduce dose for children
1536 Terbutaline Sulphate 10 mg/ml Nebulizer Solution R03AC03183A3001XX B Asthma and other conditions associated with reversible airways obstruction ADULT : 5 - 10 mg 2 -4 times daily, additional doses may be necessary in severe acute asthma. CHILD up to 3 years : 2 mg, 3 - 6 years : 3 mg, 6 - 8 years : 4 mg, over 8 years : 5 mg 2 - 4 times daily
1537 Teriflunomide 14 mg tablet L04AA31-000-T32-01-XXX A* Treatment of adult patients with relapsing remitting multiple sclerosis (MS) 14mg once daily.
1538 Terlipressin 1mg Injection H01BA04000P4001XX A* Acute oesophageal variceal bleeding 2 mg IV bolus over 1 minute. Maintenance: 1 - 2 mg IV bolus 4 - 6 hourly until bleeding is controlled, up to 24 - 36 hours. The maximum daily dosage is 120-150 mcg/kg body weight.
1539 Testosterone 250 mg/ml Injection G03BA03000P3001XX A* Only for treatment of male infertility, protein deficiency during convalescence after surgery and wasting disorder. In women, supplementary therapy of progressive mammary carcinoma By IM only. Hypogonadism 250 mg every 2-3 weeks. To maintain an adequate androgenic effect 250 mg every 3-6 weeks. Potency disorders 250 mg every 4 weeks. Male climateric disorders: 250 mg every 3-4 weeks. Repeated 6-8 weeks courses at 2-3 months interval
1540 Tetanus Toxoid Injection J07AM01000P3001XX C+ Immunization against tetanus infection 2 doses of 0.5 mL IM at an interval of 4-8 wk, followed by the 3rd dose 6-12 mth later. Booster: 0.5 mL IM every 10 yr.
1541 Tetracycline HCl 250 mg Capsule J01AA07110C1001XX B Infections caused by susceptible pathogens "Adult: 250-500 mg 6 hrly. Max: 4 g/day. Child: ≥12 yr Max: 2 g daily"
1542 Tetracycline HCl 250 mg Tablet J01AA07110T1001XX B Infections caused by susceptible pathogens "Adult: 250-500 mg 6 hrly. Max: 4 g/day. Child: ≥12 yr Max: 2 g daily"
1543 Thalidomide 50 mg Capsule L04AX02000C1001XX A* First line induction therapy in newly diagnosed multiple myeloma, salvage therapy in relapsed multiple myeloma and maintenance therapy in multiple myeloma (contraindicated for pregnant women; pregnancy test for females in reproductive age group before starting treatment should be done). 50 mg to 200 mg daily
1544 Thallous Chloride (Thallium-201) Injection V09GX01100P3001XX A* Used in myocardial perfusion scintigraphy, acute myocardial infarction and post-surgical assessment of coronary artery bypass graft patency, muscle perfusion scintigraphy, visualisation of brain and thyroid tumours and metastases As IV infusion
1545 Theophylline 125 mg Tablet R03DA04000T1001XX B Reversible airways obstruction, acute severe asthma ADULT: 125 mg 3 - 4 times daily after food, increased to 250 mg if required. CHILD: 1 - 15 years : 5 mg/kg/dose (up to 600 mg/ day) every 3 - 4 times daily
1546 Theophylline 250 mg Long Acting Tablet R03DA04000T5001XX B Reversible airways obstruction and acute severe asthma ADULT: 250 mg 2 times daily. CHILD under 12 years : Up to 10 mg/kg body weight 2 times daily
1547 Theophylline 80 mg/15 ml Syrup R03DA04000L9001XX B Reversible airways obstruction and acute severe asthma ADULT : 125 mg 3 - 4 times daily after food, increased to 250 mg if required. CHILD 1 - 15 years : 5 mg/kg/dose (up to 600 mg/day) every 3 - 4 times per day
1548 Thiamine HCl 100 mg/ml Injection A11DA01110P3001XX B i) For the prevention or treatment of Vitamin B1 deficiency syndromes including beri-beri and peripheral neuritis associated with pellagra ii) Wernicke-Korsakoff Syndrome i) Mild to chronic deficiency: 10-25 mg daily. Severe deficiency: 200- 300 mg daily ii) 500 mg every 8 hours for 2 days, followed by 100 mg 2 times daily until patient can take oral dose
1549 Thiamine Mononitrate 10 mg Tablet A11DA01221T1002XX C For the prevention or treatment of Vitamin B1 deficiency syndromes including beri-beri and peripheral neuritis associated with pellagra i) Mild to chronic deficiency: 10-25 mg daily ii) Severe deficiency: 200- 300 mg daily
1550 Thiamine Mononitrate 3 mg Tablet A11DA01221T1001XX C For the prevention or treatment of Vitamin B1 deficiency syndromes including beri-beri and peripheral neuritis associated with pellagra i) Mild to chronic deficiency: 10-25 mg daily ii) Severe deficiency: 200 - 300 mg daily
1551 Thioguanine 40 mg Tablet L01BB03000T1001XX A For acute leukaemia and chronic granulocytic leukaemia Refer to specific protocols. Usually 100 mg/m2 for 5 - 7 days (acute myeloid leukaemia) or up to 2 weeks (chronic myeloid leukaemia for accelerated/ advanced disease). CHILD: 40 - 60 g/m2 daily according to protocol
1552 Thiopental Sodium 500 mg Injection N05CA19520P3001XX B i) General anaesthesia, induction ii) Anticonvulsant for cases resistant to conventional anticonvulsants in the ICU i) ADULT : For induction 200 - 400 mg. For repeat injection 3 - 5 mg/kg over 10 - 15 seconds until desired depth of anaesthesia is obtained. Not FDA approved for use in pediatric patients ii) 75 - 125 mg IV single dose; for local-anaesthetic induced convulsion: 125 - 250 mg IV over 10 minutes
1553 Thymol Compound Gargle A01AD11985M2001XX C For sore throat and minor mouth inflammation To be gargled 3-4 times daily
1554 Thyrotropin alfa 0.9mg/ml Injection H01AB01000P3002XX A* Thyrogen (thyrotropin alfa) is indicated for use as an adjunctive treatment for radioiodine ablation of thyroid tissue remnants in patients who have undergone a near-total or total thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of distant metastatic thyroid cancer. A two-injection regimen is recommended for thyrotropin administration.The two-injection regimen is thyrotropin 0.9 mg intramuscularly (IM), followed by a second 0.9 mg IM injection 24 hours later. After reconstitution with 1.2 mL Sterile Water for Injection, 1.0 mL solution (0.9 mg thyrotropin alfa) is administered by intramuscular injection to the buttock. For radioiodine imaging or treatment, radioiodine administration should be given 24 hours following the final Thyrogen injection. Diagnostic scanning should be performed 48 hours after radioiodine administration, whereas post-therapy scanning may be delayed additional days to allow background activity to decline.
1555 Tibolone 2.5 mg Tablet G03CX01000T1001XX A* Treatment of complaints resulting from the natural or surgical menopause & in cases at high risk for breast carcinomas where general hormone replacement therapy is contraindicated 2.5mg daily
1556 Ticagrelor 90 mg Tablet B01AC24000T1001XX A* a)Patient who failed clopidogrel readmitted to hospital with recurrent atherothrombotic event while patients are on clopidogrel. b) ACS patients with:i) STEMI - going for invasive (PCI), ii) NSTEMI/UA - intermediate to high risk (based on TIMI score). iii) Other complicated ACS cases treated either medically or invasively via PCI or CABG (risk of Stent thrombosis, 3VD etc.) Initially, 180mg as single dose followed by 90mg bd with maintenance dose of ASA 75-150 mg daily.
1557 Ticlopidine HCl 250 mg Tablet B01AC05110T1001XX A/KK i) Prevention of thrombotic stroke for patients who are sensitive /intolerant to Acetysalicylic Acid ii) Maintenance of coronary bypass surgery or angioplasty iii) Maintenance of patency of access in patients on chronic haemodialysis 250 mg twice daily taken with food
1558 Timolol Maleate 0.5% Eye Drops S01ED01253D2002XX A Elevated intraocular pressure, chronic open angle glaucoma 1 drop for once daily or 2 times daily depending on manufacturer's recommendation.
1559 Tinidazole 500 mg Tablet P01AB02000T1001XX B i) Amoebiasis ii) Urogenital trichomoniasis and giardiasis i) ADULT : 2 g as a single dose for 2 - 3 days. CHILD 3 years and older : 50 mg/kg daily for 3 days ii) ADULT : 2 g as a single dose (repeated once if necessary). Sexual partners should be treated concomitantly with the same dose. CHILD 6 years and older : single dose of 1 gram
1560 Tinzaparin sodium 10,000 anti-Factor Xa IU/ml Injection in Prefilled syringe/cartridge B01AB10520P5001XX A* i)Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), not amounting to hemodynamic instability. ii)Prevention of post-operative DVT in patients undergoing general and orthopaedic surgery. i)Treatment of DVT and PE, in conjunction with warfarin: 175 anti-Factor Xa IU/kg SC once daily for at least 6 days. ii)Thromboprophylaxis in patients with:Moderate risk of thrombosis (general surgery):3,500 anti-Factor Xa IU SC 2 hrs before surgery and postoperatively, 3,500 anti-Factor Xa IU once daily for 7-10 days. High risk of thrombosis (eg. total hip replacement):4,500 anti-Factor Xa IU SC or 50 anti-Factor Xa IU/kg body weight SC 2 hrs before surgery and then once daily until the patients has been mobilized.

Halaman-halaman